2seventy bio, Inc. (TSVT) Tops Q3 EPS by 36c

2seventy bio, Inc. (NASDAQ: TSVT) reported Q3 EPS of ($1.40), $0.36 better than the analyst estimate of ($1.76). Revenue for the quarter came in at $12 million versus the consensus estimate of $13.4 million.

For earnings history and earnings-related data on 2seventy bio, Inc. (TSVT) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• DHT Holdings Q2 TCE earnings estimated at $126,700 per day
• Morgan Stanley Downgrades Tryg A/S (TRYG:DC) (TGVSF) to Underweight